Atrophic gastritis and pre-malignant gastric lesions

被引:10
|
作者
Lahner, Edith [1 ]
Esposito, Gianluca [1 ]
Galli, Gloria [1 ]
Annibale, Bruno [1 ]
机构
[1] Univ Roma La Sapienza, St Andrea Hosp, Dept Med Surg & Translat Med, I-00185 Rome, Italy
关键词
Atrophic gastritis; pernicious anemia; intestinal metaplasia; gastric cancer; type 1-gastric carcinoids;
D O I
10.3978/j.issn.2224-4778.2015.05.05
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Atrophic gastritis and intestinal metaplasia are considered to be precancerous conditions as they constitute the background in which dysplasia and intestinal-type gastric adenocarcinoma may develop. The development of the intestinal-type gastric adenocarcinoma represents the end step of an inflammation-metaplasia-dysplasia-carcinoma sequence, called the Correa cascade of multistep gastric carcinogenesis. Atrophic gastritis is associated also with type 1 gastric carcinoid whose major pathogenetic factor is hypergastrinemia. Gastrin acts as a growth factor for enterochromaffin-like cells, which in atrophic gastritis are chronically induced to proliferate, and, through a multistep process passing from hyperplasia to dysplasia, carcinoid may develop. Atrophic gastritis is a chronic disorder occurring in up to 8% of the general population. The positivity of autoantibodies against parietal cells and/or intrinsic factor, the compresence of autoimmune diseases as thyroid autoimmune disease or type 1 diabetes are frequently observed. A frequent clinical presentation of atrophic gastritis is pernicious anemia arising from vitamin B12 malabsorption as a consequence of intrinsic factor deficiency. Also iron deficiency anemia may be associated with atrophic gastritis due to iron malabsorption as a consequence of reduced gastric acid secretion together with normal or low cobalamin levels. Pernicious anemia, the possible end-stage of atrophic gastritis, is considered an autoimmune disorder. To date, there are no clear universally accepted criteria to define autoimmune gastritis and to distinguish this clinical entity from chronic Helicobacter pylori (H. pylori)-driven atrophic gastritis. In the last years, many data emerged from several studies on prevalence of atrophic gastritis and intestinal metaplasia, risk of progression of these conditions to gastric neoplasms, clinical features and detection of these precancerous changes in the gastric mucosa. The purpose of this review was to focus on these issues.
引用
收藏
页码:272 / 281
页数:10
相关论文
共 50 条
  • [1] Biopsy Strategies for Endoscopic Surveillance of Pre-malignant Gastric Lesions
    de Vries, Annemarie C.
    Haringsma, Jelle
    de Vries, Richard A.
    ter Borg, Frank
    van Grieken, Nicole C. T.
    Meijer, Gerrit A.
    van Dekken, Herman
    Kuipers, Ernst J.
    HELICOBACTER, 2010, 15 (04) : 259 - 264
  • [2] Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
    Zhang, Meng
    Liu, Shan
    Hu, Yue
    Bao, Hai-biao
    Meng, Li-na
    Wang, Xiao-teng
    Xu, Yi
    Zhao, Jing
    Lu, Bin
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Endoscopic Resection of Early Gastric Cancer and Pre-Malignant Gastric Lesions
    Vasconcelos, Ana Clara
    Dinis-Ribeiro, Mario
    Libanio, Diogo
    CANCERS, 2023, 15 (12)
  • [4] Recommendations of the Chilean association for digestive endoscopy for the management of gastric pre-malignant lesions
    Rollan, Antonio
    Cortes, Pablo
    Calvo, Alfonso
    Raularaya
    Ester Bufadel, Maria
    Gonzalez, Robinson
    Heredia, Carolina
    Munoz, Pablo
    Squella, Freddy
    Nazal, Roberto
    De Los Angeles Gatica, Maria
    Gobelet, Jaquelina
    Estay, Rene
    Pisano, Raul
    Contreras, Luis
    Osorio, Ingrid
    Estela, Ricardo
    Fluxa, Fernando
    Parra-Blanco, Adolfo
    REVISTA MEDICA DE CHILE, 2014, 142 (09) : 1181 - 1192
  • [5] Management of pre-malignant and malignant lesions by endoscopic resection
    Pech, O
    May, A
    Gossner, L
    Rabenstein, T
    Ell, C
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (01) : 61 - 76
  • [6] Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
    Vannella, L.
    Lahner, E.
    Osborn, J.
    Bordi, C.
    Miglione, M.
    Delle Fave, G.
    Annibale, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (09) : 1042 - 1050
  • [7] Does Portal Hypertension Increase the Risk of Helicobacter pylori Infection and Pre-Malignant Gastric Lesions?
    Gaspar, Rui
    Cardoso, Pedro
    Ribeiro, Tiago
    Silva, Marco
    Macedo, Guilherme
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [8] Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions
    Song, Huan
    Zhu, Jianwei
    Lu, DongHao
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [9] CCAT1 expressed in malignant and pre-malignant human gastric tissues
    Li, X.
    Zhou, Y.
    Qian, H.
    CELLULAR AND MOLECULAR BIOLOGY, 2017, 63 (05) : 89 - 93
  • [10] Gastric microbiota composition in patients with corpus atrophic gastritis
    Conti, Laura
    Borro, Marina
    Milani, Christian
    Simmaco, Maurizio
    Esposito, Gianluca
    Canali, Giulia
    Pilozzi, Emanuela
    Ventura, Marco
    Annibale, Bruno
    Lahner, Edith
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (12) : 1580 - 1587